IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 80 filers reported holding IRADIMED CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $262,984 | +6.0% | 9,296 | +12.7% | 0.05% | -1.8% |
| Q3 2022 | $248,000 | -12.1% | 8,251 | -0.7% | 0.06% | -9.8% |
| Q2 2022 | $282,000 | -25.0% | 8,312 | -0.9% | 0.06% | -4.7% |
| Q1 2022 | $376,000 | -1.6% | 8,385 | +1.5% | 0.06% | +14.3% |
| Q4 2021 | $382,000 | -14.0% | 8,262 | -60.3% | 0.06% | -46.2% |
| Q1 2020 | $444,000 | -8.6% | 20,800 | 0.0% | 0.10% | +33.3% |
| Q4 2019 | $486,000 | -18.5% | 20,800 | -26.6% | 0.08% | -21.2% |
| Q3 2019 | $596,000 | -77.9% | 28,332 | -78.5% | 0.10% | -76.2% |
| Q2 2019 | $2,694,000 | -22.3% | 131,727 | +6.7% | 0.42% | -22.7% |
| Q1 2019 | $3,467,000 | +21.4% | 123,438 | +5.8% | 0.54% | +10.9% |
| Q4 2018 | $2,855,000 | -17.9% | 116,711 | +24.7% | 0.48% | +7.8% |
| Q3 2018 | $3,477,000 | +1495.0% | 93,584 | +835.8% | 0.45% | +1263.6% |
| Q2 2016 | $218,000 | +4.3% | 10,000 | -8.4% | 0.03% | +22.2% |
| Q1 2016 | $209,000 | -31.0% | 10,922 | +1.0% | 0.03% | -18.2% |
| Q4 2015 | $303,000 | – | 10,814 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Ten Capital Management LLC | 783,066 | $30,814,000 | 5.13% |
| Soleus Capital Management, L.P. | 773,694 | $30,444,859 | 3.15% |
| RK Capital | 335,400 | $13,197,990 | 2.90% |
| Capital Impact Advisors, LLC | 19,390 | $762,997 | 0.94% |
| Ranger Investment Management | 205,692 | $8,093,980 | 0.54% |
| Bares Capital Management | 317,000 | $12,473,950 | 0.44% |
| Hillsdale Investment Management Inc. | 109,100 | $4,293,085 | 0.37% |
| CORNERCAP INVESTMENT COUNSEL INC | 37,007 | $1,456,225 | 0.26% |
| Riverwater Partners LLC | 6,234 | $245,308 | 0.22% |
| RICE HALL JAMES & ASSOCIATES, LLC | 72,271 | $2,843,864 | 0.16% |